Impact of weighted composite compared to traditional composite endpoints for the design of randomized controlled trials

Statistical Methods in Medical Research

Volumn 24, Issue 6, 2015, Pages 980-988

  Bakal, Jeffrey A ^a   Westerhout, Cynthia M ^a   Armstrong, Paul W ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

cardiovascular; composite endpoint; Trial design

Indexed keywords

CARDIOVASCULAR SYSTEM; CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; SAMPLE SIZE; BIOASSAY; CARDIOVASCULAR DISEASES; COMPARATIVE STUDY; KAPLAN MEIER METHOD; METHODOLOGY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); STATISTICAL ANALYSIS; TREATMENT OUTCOME;

CARDIOVASCULAR DISEASES; DATA INTERPRETATION, STATISTICAL; ENDPOINT DETERMINATION; HUMANS; KAPLAN-MEIER ESTIMATE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; TREATMENT OUTCOME;

EID: 84948433003     PISSN: 09622802     EISSN: 14770334     Source Type: Journal    
DOI: 10.1177/0962280211436004     Document Type: Article

References (16)

1. Ferreira-Gonzalez I, Permanyer-Miralda G, Busse JW, et al. Methodologic discussions for using and interpreting composite endpoints are limited, but still identify major concerns. J Clin Epidemiol 2007; 60 (7): 651-657.; discussion 658-662.
2. Lim E, Brown A, Helmy A, et al. Composite outcomes in cardiovascular research: a survey of randomized trials. Ann Intern Med 2008; 149 (9): 612-617.
3. Braunwald E, Cannon CP, McCabe CH,. An approach to evaluating thrombolytic therapy in acute myocardial infarction. The 'unsatisfactory outcome' end point. Circulation 1992; 86 (2): 683-687.
4. Cannon CP,. Clinical perspectives on the use of composite endpoints. Control Clin Trials 1997; 18 (6): 517-529.; discussion 546-549.
5. Ferreira-Gonzalez I, Permanyer-Miralda G, Busse JW, et al. Composite outcomes can distort the nature and magnitude of treatment benefits in clinical trials. Ann Intern Med 2009; 150 (8): 566-567.
6. Kaul S, Diamond GA,. Trial and error. How to avoid commonly encountered limitations of published clinical trials. J Am Coll Cardiol 2010; 55 (5): 415-427.
7. Senn S, Julious S,. Measurement in clinical trials: a neglected issue for statisticians? Stat Med 2009; 28 (26): 3189-3209.
8. Armstrong PW, Westerhout CM, Van de Werf F, et al. Refining clinical trial composite outcomes: an application to the Assessment of the Safety and Efficacy of a New Thrombolytic-3 (ASSENT-3) trial. Am Heart J 2011; 161 (5): 848-854.
9. Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 Investigators. Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction. Lancet 2001; 358 (9282): 605-613.
10. Armstrong PW, WEST Steering Committee,. A comparison of pharmacologic therapy with/without timely coronary intervention vs. primary percutaneous intervention early after ST-elevation myocardial infarction: the WEST (Which Early ST-elevation myocardial infarction Therapy) study. Eur Heart J 2006; 27 (13): 1530-1538.
11. Hallstrom AP, Litwin PE, Weaver WD,. A method of assigning scores to the components of a composite outcome: an example from the MITI trial. Control Clin Trials 1992; 13 (2): 148-155.
12. Sabatine MS, Cannon CP, Gibson CM, et al. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med 2005; 352 (12): 1179-1189.
13. Cantor WJ, Fitchett D, Borgundvaag B, et al. Routine early angioplasty after fibrinolysis for acute myocardial infarction. N Engl J Med 2009; 360 (26): 2705-2718.
14. Brown MM, Brown GC and Sharma S. Evidence-based to value-based medicine. United States of America, American Medical Association Press, 2005.
15. Pocock SJ, Ariti CA, Collier TJ, et al. The win ratio: a new approach to the analysis of composite endpoints in clinical trials based on clinical priorities. Eur Heart J. Epub ahead of print (September 6, 2011). (accessed 20 December 2011).
16. Bonds DE and Freedberg K. Combining utility measurements exploring different approaches. Dis Manag Health Out 2001; 9: 507-516.